Literature DB >> 22005001

Efficacy and safety of nevirapine + Kivexa (abacavir/lamivudine) as a simplification strategy for HIV patients with undetectable viral load.

Alfonso Cabello Úbeda, José Sanz Moreno, Frances Williams, Miguel Górgolas.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22005001     DOI: 10.1097/QAI.0b013e31822ccfe3

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  2 in total

1.  Long-term efficacy and toxicity of abacavir/lamivudine/nevirapine compared to the most prescribed ARV regimens before 2013 in a French Nationwide Cohort Study.

Authors:  Paul de Boissieu; Moustapha Dramé; François Raffi; André Cabie; Isabelle Poizot-Martin; Laurent Cotte; Rodolphe Garraffo; Pierre Delobel; Thomas Huleux; David Rey; Firouzé Bani-Sadr
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

Review 2.  Abacavir-induced liver toxicity.

Authors:  Maria Diletta Pezzani; Chiara Resnati; Valentina Di Cristo; Agostino Riva; Cristina Gervasoni
Journal:  Braz J Infect Dis       Date:  2016-04-04       Impact factor: 3.257

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.